Potential new therapy for KRAS-mutated CRC

被引：0
|
作者：
Nierengarten, Mary Beth
机构：
来源：
CANCER | 2024年 / 130卷 / 15期
关键词：
D O I：
10.1002/cncr.35445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Clinicopathologic features of KRAS-mutated colorectal tumors vary by site of mutation
    Morris, Van Karlyle
    Overman, Michael J.
    Eng, Cathy
    Sanchez, Eduardo Vilar
    Morelli, Maria
    Jiang, Zhiqin
    Luthra, Rajyalakshmi
    Maru, Dipen M.
    Meric-Bernstam, Funda
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer
    Jiffry, Jeeshan
    Thavornwatanayong, Thongthai
    Rao, Devika
    Fogel, Elisha J.
    Saytoo, Durvanand
    Nahata, Rishika
    Guzik, Hillary
    Chaudhary, Imran
    Augustine, Titto
    Goel, Sanjay
    Maitra, Radhashree
    CLINICAL CANCER RESEARCH, 2021, 27 (03) : 865 - 876
  • [23] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Hirata, Yuki
    Otsuki, Yuji
    Suina, Kentaro
    Saito, Yoshiyuki
    Masuda, Kenta
    Okazaki, Shogo
    Ishimoto, Takatsugu
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2022, 113 (03) : 916 - 925
  • [24] MEK inhibition suppresses metastatic progression of KRAS-mutated gastric cancer
    Yamasaki, Juntaro
    Otsuki, Yuji
    Masuda, Kenta
    Saya, Hideyuki
    Nagano, Osamu
    CANCER SCIENCE, 2023, 114 : 296 - 296
  • [25] Identification of T -cell receptors targeting KRAS-mutated human tumors
    Wang, Qiong J.
    Yu, Zhiya
    Hanada, Kenichi
    Restifo, Nicholas P.
    Yang, James C.
    CANCER RESEARCH, 2016, 76
  • [26] Genotype-guided targeted treatment of KRAS-mutated arteriovenous malformations
    Cai, R.
    Wang, Z.
    Sun, Y.
    Yang, X.
    Wen, M.
    Zheng, L.
    Wang, D.
    Yu, L.
    Fan, X.
    Su, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (09) : E708 - E710
  • [27] Not all KRAS-mutated pancreatic cancers are equal - mutant dosage matters
    Perry, Maria A.
    Varghese, Anna M.
    NATURE MEDICINE, 2025, 31 (02) : 390 - 391
  • [28] MYC inhibition by Omomyc as a therapeutic strategy for (KRAS-mutated) colorectal cancer
    Kaur, J.
    Martinez-Martin, S.
    Foradada, L.
    Lopez-Estevez, S.
    Serrano, E.
    Martin-Fernandez, G.
    Thabussot, H.
    Cano, V. Castillo
    Casacuberta-Serra, S.
    Zacarias-Fluck, M. F.
    Grueso, J.
    Beaulieu, M. E.
    Whitfield, J. R.
    Soucek, L.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S24 - S24
  • [29] Japanese experience with hepatic resection of KRAS-mutated colorectal liver metastases
    Shindoh, Junichi
    CHINESE CLINICAL ONCOLOGY, 2019, 8 (05)
  • [30] Biologic heterogeneity of KRAS-mutated lung adenocarcinomas (K-ADC)
    Huynh, Tiffany
    Gainor, Justin F.
    Nardi, Valentina
    Mino-Kenudson, Mari
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345